Geron CorpNASDAQ:GERN
- LAST PRICE4.2500
- TODAY'S CHANGE (%)-0.0400 (-0.9324%)
- Bid / Lots4.2100/ 1
- Ask / Lots4.2600/ 38
- Open / Previous Close4.2100 / 4.2900
- Day Range
- 52 Week Range
- Volume12,139,002
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GERN |
|---|---|---|
| 09:32 ET | 119228 | 4.215 |
| 09:33 ET | 33301 | 4.235 |
| 09:35 ET | 18409 | 4.28 |
| 09:37 ET | 65991 | 4.32 |
| 09:39 ET | 225228 | 4.29 |
| 09:42 ET | 35773 | 4.255 |
| 09:44 ET | 35166 | 4.21 |
| 09:46 ET | 90845 | 4.195 |
| 09:48 ET | 13266 | 4.205 |
| 09:50 ET | 70389 | 4.215 |
| 09:51 ET | 15538 | 4.2 |
| 09:53 ET | 84002 | 4.22 |
| 09:55 ET | 11434 | 4.22 |
| 09:57 ET | 29289 | 4.22 |
| 10:00 ET | 11235 | 4.205 |
| 10:02 ET | 50713 | 4.225 |
| 10:04 ET | 124901 | 4.245 |
| 10:06 ET | 52829 | 4.2484 |
| 10:08 ET | 97106 | 4.245 |
| 10:09 ET | 34772 | 4.215 |
| 10:11 ET | 18276 | 4.235 |
| 10:13 ET | 12424 | 4.25 |
| 10:15 ET | 56998 | 4.25 |
| 10:18 ET | 158057 | 4.245 |
| 10:20 ET | 24353 | 4.235 |
| 10:22 ET | 36397 | 4.25 |
| 10:24 ET | 24560 | 4.235 |
| 10:26 ET | 3226 | 4.235 |
| 10:27 ET | 20091 | 4.235 |
| 10:29 ET | 111384 | 4.25 |
| 10:31 ET | 87752 | 4.245 |
| 10:33 ET | 103094 | 4.245 |
| 10:36 ET | 21783 | 4.245 |
| 10:38 ET | 4960 | 4.245 |
| 10:40 ET | 115852 | 4.255 |
| 10:42 ET | 198856 | 4.25 |
| 10:44 ET | 62317 | 4.25 |
| 10:45 ET | 8788 | 4.245 |
| 10:47 ET | 60994 | 4.245 |
| 10:49 ET | 82659 | 4.25 |
| 10:51 ET | 207098 | 4.245 |
| 10:54 ET | 165405 | 4.225 |
| 10:56 ET | 6023 | 4.225 |
| 10:58 ET | 26572 | 4.215 |
| 11:00 ET | 36360 | 4.23 |
| 11:02 ET | 50750 | 4.21 |
| 11:03 ET | 145526 | 4.235 |
| 11:05 ET | 803628 | 4.245 |
| 11:07 ET | 67634 | 4.245 |
| 11:09 ET | 22022 | 4.235 |
| 11:12 ET | 27571 | 4.235 |
| 11:14 ET | 30308 | 4.2352 |
| 11:16 ET | 3036 | 4.235 |
| 11:18 ET | 7479 | 4.23 |
| 11:20 ET | 4246 | 4.235 |
| 11:21 ET | 36707 | 4.235 |
| 11:23 ET | 65854 | 4.24 |
| 11:25 ET | 18398 | 4.245 |
| 11:27 ET | 6526 | 4.245 |
| 11:30 ET | 11306 | 4.2403 |
| 11:32 ET | 261177 | 4.25 |
| 11:34 ET | 7476 | 4.24 |
| 11:36 ET | 36890 | 4.245 |
| 11:38 ET | 38844 | 4.25 |
| 11:39 ET | 26267 | 4.245 |
| 11:41 ET | 31628 | 4.23 |
| 11:43 ET | 200910 | 4.24 |
| 11:45 ET | 21671 | 4.245 |
| 11:48 ET | 28266 | 4.25 |
| 11:50 ET | 126183 | 4.2511 |
| 11:52 ET | 122898 | 4.24 |
| 11:54 ET | 14948 | 4.245 |
| 11:56 ET | 6604 | 4.245 |
| 11:57 ET | 77988 | 4.235 |
| 11:59 ET | 12249 | 4.235 |
| 12:01 ET | 5428 | 4.2301 |
| 12:03 ET | 8140 | 4.24 |
| 12:06 ET | 23154 | 4.24 |
| 12:08 ET | 4566 | 4.24 |
| 12:10 ET | 4891 | 4.235 |
| 12:12 ET | 72772 | 4.205 |
| 12:14 ET | 77144 | 4.19 |
| 12:15 ET | 14194 | 4.195 |
| 12:17 ET | 19233 | 4.2 |
| 12:19 ET | 15409 | 4.2 |
| 12:21 ET | 36408 | 4.215 |
| 12:24 ET | 2648 | 4.215 |
| 12:26 ET | 4569 | 4.215 |
| 12:28 ET | 11938 | 4.215 |
| 12:30 ET | 5007 | 4.215 |
| 12:32 ET | 2758 | 4.215 |
| 12:33 ET | 11038 | 4.215 |
| 12:35 ET | 30097 | 4.22 |
| 12:37 ET | 25787 | 4.22 |
| 12:39 ET | 25276 | 4.225 |
| 12:42 ET | 6516 | 4.225 |
| 12:44 ET | 4392 | 4.23 |
| 12:46 ET | 15447 | 4.225 |
| 12:48 ET | 45775 | 4.23 |
| 12:50 ET | 87215 | 4.215 |
| 12:51 ET | 46885 | 4.205 |
| 12:53 ET | 10763 | 4.205 |
| 12:55 ET | 7493 | 4.21 |
| 12:57 ET | 7509 | 4.205 |
| 01:00 ET | 9802 | 4.2025 |
| 01:02 ET | 56947 | 4.195 |
| 01:04 ET | 52052 | 4.2 |
| 01:06 ET | 8501 | 4.195 |
| 01:08 ET | 56805 | 4.175 |
| 01:09 ET | 25669 | 4.155 |
| 01:11 ET | 24120 | 4.155 |
| 01:13 ET | 10586 | 4.155 |
| 01:15 ET | 12545 | 4.155 |
| 01:18 ET | 12038 | 4.16 |
| 01:20 ET | 11550 | 4.155 |
| 01:22 ET | 158870 | 4.175 |
| 01:24 ET | 2296 | 4.175 |
| 01:26 ET | 58020 | 4.21 |
| 01:27 ET | 1941 | 4.205 |
| 01:29 ET | 5530 | 4.21 |
| 01:31 ET | 45903 | 4.2099 |
| 01:33 ET | 28817 | 4.225 |
| 01:36 ET | 4774 | 4.225 |
| 01:38 ET | 28880 | 4.245 |
| 01:40 ET | 91012 | 4.245 |
| 01:42 ET | 41528 | 4.2317 |
| 01:44 ET | 3800 | 4.235 |
| 01:45 ET | 2440 | 4.235 |
| 01:47 ET | 19534 | 4.245 |
| 01:49 ET | 5935 | 4.245 |
| 01:51 ET | 39112 | 4.24 |
| 01:54 ET | 86466 | 4.245 |
| 01:56 ET | 11674 | 4.25 |
| 01:58 ET | 6833 | 4.245 |
| 02:00 ET | 74311 | 4.245 |
| 02:02 ET | 25319 | 4.245 |
| 02:03 ET | 5321 | 4.25 |
| 02:05 ET | 13499 | 4.245 |
| 02:07 ET | 13045 | 4.245 |
| 02:09 ET | 58543 | 4.23 |
| 02:12 ET | 52988 | 4.22 |
| 02:14 ET | 19574 | 4.215 |
| 02:16 ET | 5001 | 4.21 |
| 02:18 ET | 7236 | 4.21 |
| 02:20 ET | 24084 | 4.21 |
| 02:21 ET | 18344 | 4.22 |
| 02:23 ET | 27271 | 4.22 |
| 02:25 ET | 7694 | 4.215 |
| 02:27 ET | 19135 | 4.22 |
| 02:30 ET | 19660 | 4.225 |
| 02:32 ET | 13276 | 4.225 |
| 02:34 ET | 12504 | 4.225 |
| 02:36 ET | 15138 | 4.23 |
| 02:38 ET | 49224 | 4.23 |
| 02:39 ET | 5530 | 4.225 |
| 02:41 ET | 13111 | 4.24 |
| 02:43 ET | 5614 | 4.24 |
| 02:45 ET | 73152 | 4.24 |
| 02:48 ET | 8747 | 4.235 |
| 02:50 ET | 154138 | 4.24 |
| 02:52 ET | 5508 | 4.2375 |
| 02:54 ET | 6588 | 4.235 |
| 02:56 ET | 57942 | 4.24 |
| 02:57 ET | 74722 | 4.245 |
| 02:59 ET | 15076 | 4.235 |
| 03:01 ET | 18735 | 4.235 |
| 03:03 ET | 67369 | 4.2429 |
| 03:06 ET | 45407 | 4.245 |
| 03:08 ET | 4715 | 4.245 |
| 03:10 ET | 10107 | 4.245 |
| 03:12 ET | 6144 | 4.245 |
| 03:14 ET | 21228 | 4.235 |
| 03:15 ET | 32974 | 4.24 |
| 03:17 ET | 7557 | 4.235 |
| 03:19 ET | 3812 | 4.235 |
| 03:21 ET | 3415 | 4.235 |
| 03:24 ET | 4788 | 4.235 |
| 03:26 ET | 68068 | 4.235 |
| 03:28 ET | 6128 | 4.235 |
| 03:30 ET | 7429 | 4.235 |
| 03:32 ET | 30526 | 4.24 |
| 03:33 ET | 21246 | 4.235 |
| 03:35 ET | 64448 | 4.235 |
| 03:37 ET | 27746 | 4.235 |
| 03:39 ET | 9473 | 4.235 |
| 03:42 ET | 53169 | 4.235 |
| 03:44 ET | 30594 | 4.23 |
| 03:46 ET | 9890 | 4.235 |
| 03:48 ET | 87724 | 4.225 |
| 03:50 ET | 89096 | 4.215 |
| 03:51 ET | 91837 | 4.21 |
| 03:53 ET | 411613 | 4.25 |
| 03:55 ET | 224695 | 4.235 |
| 03:57 ET | 518617 | 4.25 |
| 04:00 ET | 1711732 | 4.25 |
Nov 7, 2024
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million, from 7:10AM ET on Thursday Nov 07, 2024 by Dow Jones
7:10AM ET on Thursday Nov 07, 2024 by Dow JonesGeron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors, from 7:01AM ET on Thursday Nov 07, 2024 by Dow Jones
7:01AM ET on Thursday Nov 07, 2024 by Dow JonesGeron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Geron 3Q Loss/Shr 4c >GERN, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
DJ Geron Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 1:54PM ET on Wednesday Nov 06, 2024 by Dow Jones
1:54PM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Geron Corp | 2.6B | -11.8x | --- |
Scholar Rock Holding Corp | 2.6B | -13.1x | --- |
SpringWorks Therapeutics Inc | 2.5B | -7.7x | --- |
Belite Bio Inc | 2.5B | -66.2x | --- |
Soleno Therapeutics Inc | 2.5B | -17.2x | --- |
CG Oncology Inc | 2.7B | -34.2x | --- |
Company Information
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Contact Information
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250FOSTER CITY, CA, United States 94404
- Phone
- 650-473-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Scarlett
- Chief Financial Officer, Executive Vice President - Finance, Treasurer
- Michelle Robertson
- Executive Vice President, Chief Operating Officer
- Andrew Grethlein
- Chief People Officer, Senior Vice President
- Shannon Odam
- Executive Vice President, Chief Legal Officer, Secretary
- Scott Samuels
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 602.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $-0.36 |
Book Value | $0.46 |
P/E Ratio | -11.8x |
Price/Sales (TTM) | 1,865.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,559.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
